CTRI/2014/01/004332招募中4 期
Effect of Ranolazine on improvement of left ventricular dysfunction in patients with Chronic Stable Angina â?? a randomized controlled clinical trial. - EFFORT-LVR
SRM Medical College Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients who have sustained STEMI more than 12 weeks ago.
- •2.Left ventricular ejection fraction <= 40%
- •3.Willing to give written informed consent and comply with all study related procedures
排除标准
- •1.h/o undergoing CABG or stenting procedure within the last 12 weeks.
- •2.Co-existing end-stage pulmonary, or hepatic disease
- •3.Valvular heart disease
- •4.Patient consumed other study medication in the last 3 months.
- •5.Unwilling to comply with study related procedures
研究者
相似试验
招募中
Unknown
Effect of add-on therapy with Ranolazine on reducing tissue ischemia and improvement of clinical outcome in patients with severe burBurn.Burn and corrosion of head, face, and neckIRCT20210524051384N10Rasht University of Medical Sciences78
已完成
2 期
Ranolazine Mediated PVC Reduction in Ischemic Heart DiseaseVentricular Premature ComplexesMyocardial IschemiaNCT02360397Kent Hospital, Rhode Island6
终止
不适用
Effect of Ranolazine on Echocardiographic Indices of Diastolic DysfunctionRanolazineTissue Doppler UltrasoundEchocardiographyDiastolic Heart FailureNCT00574756University of California, San Diego14
已完成
4 期
The effect of Pioglitazone on Cardiovascular and Psychiatric status of non-Diabetic Metabolic Syndrome PatientsMetabolic Syndrome.Metabolic disorder, unspecifiedIRCT201101023733N2Osvah Pharmaceutical Company140
进行中（未招募）
4 期
The effect of Pioglitazone on Cardiovascular and Psychiatric status of non-Diabetic Metabolic Syndrome PatientsMetabolic SyndromeMental health screening indicatorsMetabolic and Endocrine - Other metabolic disordersMental Health - Other mental health disordersACTRN12611000351910Osvah Pharmaceutical Company140